Date | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) | Dividend Yield |
---|
CEO | Mr. Zhongxiong Peng |
IPO Date | June 30, 2015 |
Location | China |
Headquarters | No.8 Lizhishan Road |
Employees | 3,404 |
Sector | Health Care |
Industries |
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases. It also provides blood gas, optical coagulation, and dry chemistry analyzers. The company was founded in 1992 and is headquartered in Guangzhou, China.
Past 5 years
USD 3.45
USD 10.09
USD 2.09
USD 1.72
StockViz Staff
January 15, 2025
Any question? Send us an email